Curated GI articles December 2nd, 2022: One GI continues expansion | AGA’s venture capital fund makes first investment in Virgo | A $615M endobariatric deal

Curated GI articles December 2nd, 2022: One GI continues expansion | AGA’s venture capital fund makes first investment in Virgo | A $615M endobariatric deal

Curated GI articles December 2nd, 2022:
One GI continues expansion | AGA’s venture capital fund makes first investment in Virgo | A $615M endobariatric deal
What the election results mean for GI (AGA)
The majorities in both chambers are razor thin and compromises will need to be made to pass funding bills and other priorities.
One GI Continues Eastern US Expansion (PR Newswire)
One GI®, a gastroenterology management services organization, has partnered with The Colon, Stomach, and Liver Center (CSL) and Loudoun Endoscopy Group in Lansdowne, VA.
AI-Fueled Endoscopy Capture and Clinical Trials Platform, Virgo Surgical Video Solutions, Receives Support From American Gastroenterological Association Venture Fund (Newswire)
Virgo is the fund’s first investment. Through the venture fund, GIs can join AGA to invest in fast-growing, early-stage companies that are transforming care for patients with digestive disease.
Boston Scientific to buy Apollo Endosurgery for $615M as entry into endobariatric market (Medtech Dive)
The acquisition may complement Boston Scientific’s endoscopy business as it targets GI endoscopists while allowing the company to enter the endobariatric market.
What gastroenterology leaders are most excited about (Becker’s GI & Endoscopy)
Gastroenterology leaders are keeping their eyes on technological innovations as the field continues to evolve.
With FDA nod for its fecal microbiome therapy, Ferring becomes No. 1 in No. 2 (Fierce Pharma)
U.S. officials have approved the first pharmaceutical-grade version of fecal transplant procedures that doctors have increasingly used against hard-to-treat intestinal infections.
Debating the Clinical Trial Upending Colonoscopy Practices (Medscape)
Dr. David Johnson and Dr. Kenny Lin discuss colon cancer screening, the controversial NEJM colonoscopy study, and more.
$15M malpractice suit brought against Virginia GI center alleging medical negligence (Becker’s GI & Endoscopy)
The lawsuit alleges that the hospital was negligent by failing to provide a GI specialist, failing to implement a contingency plan.
Novel Liquid Biopsy Found More Reliable For Diagnosing NASH Than Current Strategies (GI & Endoscopy News)
A novel liquid biopsy has proven to be accurate, sensitive and specific in diagnosing the presence and severity of nonalcoholic steatohepatitis/liver fibrosis and is more reliable than currently used biomarkers.
Could Gut-Directed Hypnotherapy Be The Answer To Irritable Bowel Syndrome? (Women’s Health)
According to some experts, gut-directed hypnotherapy is worth looking into for patients dealing with irritable bowel syndrome or other gastrointestinal woes.
Navigating the Therapeutic Landscape for IBD (ReachMD)
Dr. Peter Buch speaks with Dr. Aline Charabaty from the Sibley Memorial Hospital on available medications, and the development of new therapeutics for IBD.
Diversity, Equity, and Inclusion in Gastroenterology and Hepatology: A Survey of Where We Stand (AJG)
The survey aimed to assess current perspectives of racial and ethnic workforce diversity and healthcare disparities among gastroenterology (GI) and hepatology professionals in the United States.
New study provides evidence for three-year interval for multi-target stool DNA screening for those at average risk of colon cancer (Regenstrief Institute)
The results suggest that at least a three-year interval between screenings using this method is clinically appropriate.
Most patients say their healthcare provider’s digital tools are underwhelming, survey finds (MM+M)
Patients are struggling with their healthcare provider’s digital tools despite increased investment in the technology, according to a new notable survey.
The EMR/ESD Hybrid or Precutting EMR Endoscopic Resection Technique (GI & Endoscopy News)
The article shows a technique of advanced endoscopic resection to improve complete entrapment and resection of colorectal, esophageal and stomach lesions.
Weird Theory Suggests IBS Caused by Body’s Inability to Manage Gravity (Newsweek)
A new theory about the underlying causes of irritable bowel syndrome (IBS) suggests that the condition could result from the body’s inability to withstand gravity.

More Hot headlines in GI

Dr. Jonathan Ng, CEO of Iterative Health: Not using computer vision is a barrier to health equity. But will it replace GIs? (NextServices)

ASGE to collaborate on endoscopy simulation training (Becker’s GI & Endoscopy)

2 gastroenterologists making headlines (Becker’s GI & Endoscopy)

Phenotype-tailored diets ‘set patients up for success’ in weight loss, health outcomes (Healio)

Personalis and UCSF to Study Clinical Utility of ctDNA for Treatment Response in Colorectal Cancer (Business Wire)

All Physicians Are Leaders: American Association for Physician Leadership to Debut Annual Conference in Chicago, Illinois June 9-11, 2023 (PR Newswire)

CRO start­up Vial scores $67M Se­ries B led by General Catalyst (Endpoints News)

Salix Pharmaceuticals Culminates Year-Long Constipation Awareness Campaign with New Social Media and Digital Initiatives Empowering Patients to Discuss Their Symptoms with a Health Care Provider (Investing News)

The TikTok Trend That Triggered a Diabetes Drug Shortage (Medscape)

HHS Moving into 2023 with Eyes on Health Equity, Public-Private Partnerships in Value-Based Programs (Hospice News)

Videos: Interviews with GI Leaders  (Scope Forward Show/NextServices)

COVID-19: The Way Forward for Gastroenterology Practices
COVID-19 is a double whammy of both clinical and business disruption. This ebook will help you explore possible scenarios and be a guide in your plans for the future.

Write a Comment